Comparison Chart Protagonist Therapeutics, Inc.

Equities

PTGX

US74366E1029

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:00 2026-02-06 EST			5-day change	1st Jan Change
84.49 ^USD	+4.74%		+3.29%	-3.26%

01-28	Protagonist Therapeutics Insider Sold Shares Worth $4,063,743, According to a Recent SEC Filing	MT
01-13	Protagonist Therapeutics, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 08:15 AM

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5d. change	Varia. Jan 1.	1-year change	5-years change	Capi.	ST	MT	LT
	PROTAGONIST THERAPEUTICS, INC.	Other Biotechnology & Medical Research	+4.74%	+3.29%	-3.26%	+117.31%	+277.52%	5.28B